Adage Capital Partners
LEGN icon

Adage Capital Partners’s Legend Biotech LEGN Stock Holding History

Adage Capital Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3M Buy
+600,000
New +$16.2M 0.02% 563
2024
Q1 		– Sell
-615,000
Closed -$37M – 921
2023
Q4 		$37M Sell
615,000
-1,093,510
-64% -$69.3M 0.08% 266
2023
Q3 		$115M Buy
1,708,510
+860,410
+101% +$59.8M 0.26% 82
2023
Q2 		$58.5M Buy
+848,100
New +$55.4M 0.13% 176
2022
Q4 		– Sell
-579,052
Closed -$23.6M – 1019
2022
Q3 		$23.6M Sell
579,052
-620,948
-52% -$29.1M 0.06% 361
2022
Q2 		$66M Buy
1,200,000
+390,000
+48% +$16.5M 0.15% 141
2022
Q1 		$29.4M Buy
810,000
+350,000
+76% +$13.8M 0.06% 341
2021
Q4 		$21.4M Buy
460,000
+210,000
+84% +$10.7M 0.04% 442
2021
Q3 		$12.6M Buy
+250,000
New +$10.4M 0.02% 627
2021
Q2 		– Sell
-1,300,000
Closed -$37.7M – 1041
2021
Q1 		$37.7M Sell
1,300,000
-700,000
-35% -$19.1M 0.08% 275
2020
Q4 		$56.3M Buy
2,000,000
+272,733
+16% +$7.85M 0.12% 189
2020
Q3 		$53.3M Buy
1,727,267
+692,095
+67% +$23.3M 0.13% 171
2020
Q2 		$44.1M Buy
+1,035,172
New +$40.4M 0.11% 205

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Adage Capital Partners's LEGN Position: Q2 2026 in Review

Adage Capital Partners opened a new position in Legend Biotech (LEGN) in Q2 2026: 600,000 shares worth $17.3M. The stake represents 0.02% of the portfolio and ranks #563 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in LEGN as recently as Q4 2023.

Adage Capital Partners first reported a position in LEGN in Q2 2020 and has held it in 13 quarters since. The position peaked at $115M in Q3 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Adage Capital Partners held 600,000 shares of Legend Biotech worth $17.3M as of Q2 2026.
  • Legend Biotech was a new Adage Capital Partners position in Q2 2026.
  • Legend Biotech made up 0.02% of Adage Capital Partners's portfolio in Q2 2026, its #563 holding.
  • Adage Capital Partners first reported a position in Legend Biotech in Q2 2020 and has held it in 13 quarters since.
  • Adage Capital Partners's Legend Biotech position peaked at $115M in Q3 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.